Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach–Merritt Syndrome and Heart Failure in a Neonate
Journal
Pediatrics and Neonatology
Journal Volume
58
Journal Issue
2
Pages
191-193
Date Issued
2017
Author(s)
Abstract
While hepatic hemangiomas are the most common hepatic tumors in children, giant hepatic hemangiomas with clinical symptoms in neonates are rare.1 Accompanying complications, such as Kasabach–Merritt syndrome and cardiac failure, result in a high mortality rate in affected neonates.2 There is no consensus on the treatment for critical hepatic hemangiomas. Besides medical treatment, local treatment such as endovascular intervention is an alternative.
SDGs
Other Subjects
alpha fetoprotein; D dimer; fibrin; fibrinogen; hemoglobin; microsphere; polymer; propranolol; abdominal distension; abdominal radiography; angiography; Article; auscultation; bleeding; body weight; breathing rate; carotid artery bruit; case report; chemoembolization; clinical effectiveness; digital subtraction angiography; disease association; disseminated intravascular clotting; echocardiography; echography; fever; fibrinolysis; follow up; gestational age; heart muscle contractility; heart rate; hemangioma; hemoglobin blood level; hepatic artery; hepatomegaly; high output heart failure; hospital admission; hospital discharge; human; hydrogel; Kasabach Merritt syndrome; laboratory test; leukocytosis; liver hemangioma; liver tumor; male; medical history; middle cerebral artery; newborn; newborn disease; nuclear magnetic resonance imaging; partial thromboplastin time; patient satisfaction; physical examination; prothrombin time; pulsatility index; risk factor; tachycardia; tachypnea; thrombocyte count; thrombocytopenia
Publisher
Elsevier (Singapore) Pte Ltd
Type
journal article